EyeGate Pharmaceuticals, Inc.
(NASDAQ : EYEG)

( )
EYEG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.24%178.580.4%$137.09m
PRGOPerrigo Co. Plc
0.48%73.346.8%$93.10m
JAZZJazz Pharmaceuticals Plc
0.68%163.032.2%$71.22m
MNKMallinckrodt Plc
-0.40%29.6721.1%$65.61m
ENDPEndo International Plc
0.13%15.968.9%$57.71m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.98%153.646.8%$51.91m
PTLAPortola Pharmaceuticals, Inc.
1.31%28.637.7%$39.01m
UTHRUnited Therapeutics Corporation
-0.27%125.8614.4%$38.69m
SAGESAGE Therapeutics, Inc.
-1.45%144.839.6%$36.37m
CTLTCatalent Inc
-0.33%42.742.4%$36.15m
ICPTIntercept Pharmaceuticals, Inc.
-1.03%119.3618.7%$32.09m
SUPNSupernus Pharmaceuticals, Inc.
2.13%47.906.2%$28.67m
PCRXPacira Pharmaceuticals, Inc.
7.32%51.3510.6%$27.64m
ZGNXZogenix, Inc.
-3.29%47.0510.0%$27.47m
MDCOMedicines Company
-0.18%33.6021.8%$24.49m

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.